Roswell Park Newsroom

Expert Database

Roswell Park Public Affairs

Annie Deck-Miller
Senior Media Relations Manager
716-845-8593
Annie.Deck-Miller@roswellpark.org
Deb Pettibone
Public Information Specialist
716-845-4919
Deborah.Pettibone@roswellpark.org

Roswell Park Alliance Foundation

Amy Biber
Director, Development Marketing And Communications
716-845-1038
Amy.Biber@RoswellPark.org

 

News In Brief

Thursday, November 3, 2016
Immunotherapy, which uses the body’s own immune system to fight disease, is transforming the treatment of several types of cancers. Severe adverse effects can result from these groundbreaking cancer treatments, however, and when they do, it’s important to recognize and quickly address them, researchers write in the New England Journal of Medicine.
Tuesday, November 1, 2016
How to harness the immune system to improve the outcome of ovarian cancer patients was the focus of a presentation by Kunle Odunsi, MD, PhD, Deputy Director of Roswell Park Cancer Institute, at the 16th Biennial Meeting of the International Gynecologic Cancer Society in Lisbon, Portugal.
Friday, October 28, 2016
The first comprehensive study analyzing follow-up care among childhood cancer survivors concludes that fewer than than half of the adult survivors of childhood cancers — who remain at greater risk for chronic illnesses — receive adequate long-term follow-up care.

Cancer Talk Blog

Wednesday, February 22, 2017 - 2:38pm

Thyroid nodules are common and found in 10 percent of the adult population. Luckily, 95 percent of them are benign. When a thyroid nodule is suspicious - meaning that it has characteristics that suggest thyroid cancer - the next step is usually a fine needle aspiration biopsy (FNAB).

Monday, February 20, 2017 - 10:57am

If your treatment plan includes surgery, the recovery process may seem overwhelming. You may be on a restricted diet or experience limited movement and pain after a major operation. Enhanced Recovery After Surgery (ERAS) is a program that allows for a smoother, faster recovery by changing the way you prepare for surgery and your post-op care.

Saturday, February 18, 2017 - 10:26am

The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.

In January 2017, the agency, a member institution of the National Institutes of Health, launched the NCI Formulary to expand access to both approved drugs and investigational agents — that is, drugs still in development — that have shown promise as possible cancer therapies.